Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -126.84% | -62.85% | 38.43% | -68.30% | 5.93% |
| Total Depreciation and Amortization | -39.74% | -34.80% | 158.54% | -22.30% | -15.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 77.61% | 19.95% | -153.20% | -19.43% | -36.34% |
| Change in Net Operating Assets | 205.48% | 31.72% | -3.19% | 5,969.70% | -150.88% |
| Cash from Operations | -121.00% | -82.89% | 23.02% | -46.68% | -21.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 53.45% | -157.64% | -248.17% | -152.72% |
| Issuance of Common Stock | -- | -- | 980,200.00% | -100.00% | -99.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -101.42% | 18,016.08% | -251.85% | -- |
| Foreign Exchange rate Adjustments | 998.21% | 109.79% | -2,015.52% | 106.41% | -119.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.26% | -156.65% | 474.92% | -23.12% | -91.45% |